Skip to main content

Philip Morris International meets with FDA to make its case for Iqos in patent dispute

Philip Morris International met with the FDA on Friday to present its argument for why the tobacco giant should be allowed to import and sell Iqos devices.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.